Enterprise Ireland's International Investor Forum in London
Enterprise Ireland presents investment opportunities in Irish companies to international investors
Over 114 venture capital, Corporate and other investors from North America, Britain, Mainland Europe and Asia are attending the Enterprise Ireland International Investor Forum in London today (Wednesday 21 November 2012), to meet 25 Irish companies from a variety of sectors including Financial Services, Cleantech, Software and Lifesciences. The forum is aimed at getting new investment to fund the significant growth plans of these companies. The new investment is being sought on the basis of syndicated investment between Irish and International VCs.
This is the fifth year the event is taking place, where the 25 Irish companies will make presentations to the international investors and leading Irish VC firms, as well as taking part in over 150 formal meetings.
This increased interest augurs well for the syndicated investments between Irish and International VCs. In the last five years, over 50 international VCs have invested in Irish companies and syndicated with Irish Venture Capital firms.
The Irish banking sector will also be represented at the event by Bank of Ireland and AIB, who are working closely with Enterprise Ireland and gaining greater understanding of the funding needs of high potential Irish SMEs. At the event, the Irish banks will have the opportunity to share perspectives with other investors including Silicon Valley Bank.
Niall O'Donnellan Enterprise Ireland's Divisional Manager for Investment Services stated: "The wide spread of international investors from the Far East, Mainland Europe, The UK and North America attending Enterprise Ireland's International Investor Forum in London on 21 November to meet Irish companies is indicative of the many high quality internationally focused growth companies now emerging out of Ireland. These companies will have an increasingly positive impact on Irish exports and jobs over the coming years".
For further information contact: